The abstract is read at the publisher; the summary is JClub's.
Non-phosphorylatable MAFA in Mafa4A/+ knock-in mice markedly increases MAFA stability and causes sex-specific pancreatic disease: males develop rapid glucose intolerance on HFD, while females develop hypoglycemia with inflammatory cystic ducts and MCNs.
- Why it matters: GSK3-mediated MAFA phosphorylation is known to regulate beta-cell function, but its in vivo roles in maintaining beta-cell identity and driving sex-biased disease outcomes remain unclear.
- What they did: The study engineered Mafa4A/+ mice with non-phosphorylatable MAFA, assessed MAFA stability, performed high-fat diet phenotyping, used bulk RNA sequencing for cell-identity changes, and applied lineage tracing to test beta-to-delta reprogramming.
- The result: In males on HFD, impaired glucose-stimulated insulin secretion accompanies disrupted beta-cell identity with increased MODY-associated genes and a delta-cell signature; in females, age-linked inflammatory cystic ducts with mucinous cystic neoplasms emerge, and MAFA protein is detected in MCN biopsies from female patients.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.